Piper Lays Out Reasons To Buy Vertex With Stock Near 52-Week Lows

Shares of Vertex Pharmaceuticals are trading near 52-week lows following the company's "weak" Q3 guidance.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.